FibroBiologics Files Patent for Advanced Wound Healing Technology
![FibroBiologics Files Patent for Advanced Wound Healing Technology](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
FibroBiologics Patent Application for Wound Healing Technology
FibroBiologics, Inc. (Nasdaq: FBLG) has announced the filing of a patent application with the United States Patent Office for a novel use of fibroblast cell-based technology in an adhesive bandage intended for wound healing.
Innovative Applications in Wound Care
"Our ongoing exploration of therapeutic applications using fibroblast cells continues to provide unique opportunities for our wound care platform," commented Founder & CEO of FibroBiologics, Pete O’Heeron. "This patent, if issued, will allow us to pursue development of a room-temperature, shelf stable bandage that could be used in the post-surgical and retail setting."
Transforming Wound Care with Fibroblast Technology
According to the company's Chief Scientific Officer, Hamid Khoja, Ph.D., "We believe that leveraging the unique healing capabilities of fibroblasts has the potential to transform wound care as we know it. Combining the healing properties of fibroblasts with a stable, long-term delivery system could allow us to make advanced treatments more accessible to a wider audience."
About FibroBiologics
FibroBiologics is a clinical-stage biotechnology company focused on developing treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company holds over 160 US and international patents or patents pending across various clinical pathways, including areas such as disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. Their research and technology represent a new era in cell therapy.
Contact Information
General Inquiries:
info@fibrobiologics.com
Investor Relations:
Nic Johnson
Russo Partners
212-845-4242
fibrobiologicsIR@russopr.com
Media Contact:
Liz Phillips
Russo Partners
(347) 956-7697
Elizabeth.phillips@russopartnersllc.com
Frequently Asked Questions
What is the focus of FibroBiologics?
FibroBiologics focuses on developing therapeutics and potential cures for chronic diseases using fibroblast cells.
What technology does the new patent application cover?
The patent application covers the use of fibroblast cell-based technology in adhesive bandages for wound healing.
How does fibroblast technology benefit wound care?
Fibroblast technology has unique healing properties that can enhance wound care solutions, making them more effective.
Where is FibroBiologics based?
FibroBiologics is based in Houston.
How many patents does FibroBiologics hold?
FibroBiologics holds over 160 patents issued and pending, covering various clinical pathways.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/